A COhort Study on Factors Leading to Vulnerability in Adult Patients With Serious Medical cOnditionS: the COSMOS-I Trial

Official record

Identifier

NCT07740239

Recruiting locations

country

Finland

Interventions studied

Test set to determine vulnerability

Lead sponsor

Tampere University Hospital

Target enrolment

2050 participants

Study type

OBSERVATIONAL

Phase

Not provided in the official record

Status

Recruiting

First posted

Jul 31, 2026

Last updated on the registry

Jul 31, 2026

Age

Not provided in the official record

Sex

MALE

Study contact

The official record lists a study contact. Contact details are published there and are intentionally not copied to this page.

Eligibility criteria

Reproduced verbatim from the official record. Eligibility is decided by the study team, never by this page.

Inclusion Criteria:

* Suspected or diagnosed disease
* ≥60 years old patients, except for patients receiving high-dose chemotherapy and stem cell transplantion who need to be ≥18 years old
* Cross-sectional imaging maximum 45 days prior to consenting or before the next treatment line
* Patients with cancer (other than patients with prostate cancer treated with hormonal treatment before radiation treatment): study procedures (excluding image analyses) must have been carried out maximum 1 month prior to the start of a new treatment line
* Patients with prostate cancers receiving hormonal treatment before radiation treatment): study procedures (excluding image analyses) must be carried out maximum 3 months after the start of hormonal treatment
* Patients with other conditions: study procedures (excluding image analyses) must have been carried out maximum 4 days after the start of the hospitalization

Exclusion Criteria:

* Not willing or unable to give written consent
* Patient not deemed suitable for the study by the researcher approaching the patient

Indexed under

Lung Cancer